Cargando…

A Review of Dietary Therapy for IBD and a Vision for the Future

Inflammatory bowel disease (IBD) is a chronic inflammatory condition affecting the gastrointestinal tract. The rising incidence of IBD has been associated with urbanization and shifts toward a Westernized diet. The intestinal microbiome has been a focus of disease pathogenesis and also therapeutic i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Nicole, Miller, Talya, Suskind, David, Lee, Dale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566428/ https://www.ncbi.nlm.nih.gov/pubmed/31035465 http://dx.doi.org/10.3390/nu11050947

Ejemplares similares

Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
por: Barnes, Alex, et al.
Publicado: (2022)

Differences in Nutrient Intake with Homemade versus Chef-Prepared Specific Carbohydrate Diet Therapy in Inflammatory Bowel Disease: Insights into Dietary Research
por: Morrison, Alex, et al.
Publicado: (2021)

Differences in Dietary Patterns of Adolescent Patients with IBD
por: Kikut, Justyna, et al.
Publicado: (2021)

The Role of Dietary Fibers in the Management of IBD Symptoms
por: Di Rosa, Claudia, et al.
Publicado: (2022)

Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies
por: Reznikov, Elizabeth A., et al.
Publicado: (2023)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Editorial: Current trends and future management of IBD
por: Estevinho, María Manuela, et al.
Publicado: (2023)

Treatment goals in IBD: A perspective from patients and their partners
por: Peek-Kuijt, Niene M.S., et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio (NLR) in Canine Inflammatory Bowel Disease (IBD)
por: Benvenuti, Elena, et al.
Publicado: (2020)

Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
por: Ban, Quan-Yao, et al.
Publicado: (2022)

A Vision for the Future
por: Schwartz, David A.
Publicado: (2005)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD
por: Armstrong, Heather, et al.
Publicado: (2021)

Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future
por: de Oliveira, Ellen Cristina Souza, et al.
Publicado: (2023)

Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD Therapy
por: Wiendl, Maximilian, et al.
Publicado: (2021)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
por: Dudek, Patrycja, et al.
Publicado: (2021)

Novel Small Molecules in IBD: Current State and Future Perspectives
por: Jefremow, André, et al.
Publicado: (2023)

A143 SAFETY OF BIOLOGICAL THERAPIES IN ELDERLY IBD: A SYSTEMATIC REVIEW
por: Golovics, P, et al.
Publicado: (2022)

Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series
por: Kaenkumchorn, Tanyaporn, et al.
Publicado: (2022)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

A vision for the future?
por: Baum, M
Publicado: (2001)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

Editorial: Microbiome in IBD: From Composition to Therapy
por: Zhu, Ruixin, et al.
Publicado: (2021)

Prognostic Factors of Biologic Therapy in Pediatric IBD
por: Buczyńska, Anna, et al.
Publicado: (2022)

Short and Long-Term Innovations on Dietary Behavior Assessment and Coaching: Present Efforts and Vision of the Pride and Prejudice Consortium
por: Lucassen, Desiree A., et al.
Publicado: (2021)

The Effects of the COVID Pandemic on Patients with IBD: Lessons Learned and Future Directions
por: Zhang, Eva, et al.
Publicado: (2022)

Visions for Future
Publicado: (2009)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Experience of Hospital Admission and Surgery During the COVID-19 Pandemic: a Survey of IBD Patients
por: Lan, Nan, et al.
Publicado: (2020)

Dreams and Visions
por: Hoff, N. S.
Publicado: (1891)

Integrated IBD Analysis, GWAS Analysis and Transcriptome Analysis to Identify the Candidate Genes for White Spot Disease in Maize
por: Wang, Dong, et al.
Publicado: (2023)

A47 MICROBIAL FUNCTIONS AS BIOMARKERS OF PRO-INFLAMMATORY RESPONSE TO SELECT DIETARY FIBERS IN IBD
por: Armstrong, H, et al.
Publicado: (2022)

OC.10.2 A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION
por: Pisani, L.F., et al.
Publicado: (2022)

Factors Predicting the Adherence to the Therapy of Italian IBD Patients
por: Bucci, Cristina, et al.
Publicado: (2017)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

The Determination of Normal Vision
por: Perkins, Francis M.
Publicado: (1881)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Fungal microbiota dysbiosis in IBD
por: Sokol, Harry, et al.
Publicado: (2017)

Zebrafish model for IBD
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_notp9h69f0uif5cor9rud04h7m